Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Sanofi Ventures

Profile, fund size and portfolio

Parent SanofiHQ Cambridge, United StatesFounded 2012

Sanofi Ventures is the corporate venture arm of Sanofi, a pharmaceutical and biotech company. It was founded in 2012 and is based in Cambridge, United States. It invests from seed to Series B. Sectors it names: biotech and life sciences, healthcare and digital health.

AUM or capital under managementS5
USD 1.4bn+
Companies backedS5
70+
IPOsS3
16

Every figure links to its source

Snapshot

Investment stage: Seed to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series B
SectorsBiotech and life sciences, Healthcare and digital health
GeographyNorth America, Europe, Asia, Middle East and Africa, Oceania
OfficesCambridge, United States, Paris, France

Sources: S4 Sanofi Ventures approach; S3 Sanofi Ventures portfolio (status and location per card).

Graphic 1 of 3

Investment stage: Seed to Series B

Sources: S4 Sanofi Ventures approach; S3 Sanofi Ventures portfolio (status and location per card).

Download:Report a correction
Investments closed by outcome
Data behind this graphic
Data behind this graphic
ItemCompaniesShare
Active6071.4%
Exited2428.6%

Status as the firm tags it

Sources: S3 Sanofi Ventures portfolio (status and location per card).

Graphic 2 of 3

Investments closed by outcome

Sources: S3 Sanofi Ventures portfolio (status and location per card).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 1.4bn+AUM or capital under managementStated by the firm or its parentS5
Companies backed70+companiesStated by the firmS5
IPOs16IPOsStated by the firmS3
Companies on the firm's portfolio page84companiesCounted from the firm's own listS3

Sources: S5 Sanofi press release: additional USD 625 million to Sanofi Ventures (24 Sep 2025); S3 Sanofi Ventures portfolio (status and location per card).

Graphic 3 of 3

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S5 Sanofi press release: additional USD 625 million to Sanofi Ventures (24 Sep 2025); S3 Sanofi Ventures portfolio (status and location per card).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Cambridge, United States
Offices

Investment regionsS4S3

LeadersS2

Sanofi Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companySanofiSingle sourceS5
Parent industryPharmaceuticals and biotechSingle sourceS5
Founded2012Single sourceS5
HeadquartersCambridge, United StatesSingle sourceS2
StatusActiveSingle sourceS5
Capital sourceParent company onlySingle sourceS5
Headline sizeUSD 1.4bn+ (AUM or capital under management)Single sourceS5
Companies backed70+Single sourceS5
Exits24 total, 16 IPOsSingle sourceS3
People on the team page12Single sourceS2
StagesSeed, Series A, Series BSingle sourceS4

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeSource
Bluebird BioIPOS3
Common SensingAcquisitionS3
Curevo VaccineAcquisitionS3
CurisiumAcquisitionS3
Escient PharmaceuticalsAcquisitionS3
Fate TherapeuticsIPOS3
Fulcrum TherapeuticsIPOS3
GlycoMimeticsIPOS3
IcosavaxAcquisitionS3
Immune DesignIPOS3
Inozyme PharmaAcquisitionS3
KaloBiosIPOS3
Kymera TherapeuticsIPOS3
LAVA TherapeuticsIPOS3
Lumena PharmaceuticalsAcquisitionS3
Lysosomal TherapeuticsAcquisitionS3
MacroGenicsIPOS3
Ovid TherapeuticsIPOS3
Proteostasis TherapeuticsIPOS3
Selecta BiosciencesIPOS3

Portfolio

The firm's portfolio page lists 84 companies: 60 active, 24 exited.S3

The firm also states 70+ companies backed. The page list and the stated total measure different things.S5

Companies by status on the firm's list. Status as the firm tags itS3
TagCompaniesShare
Active6071.4%
Exited2428.6%

Shared portfolio with other corporate VCs

28 companies on the Sanofi Ventures portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
Pfizer Ventures4Normunity, ReCode Therapeutics, Kymera Therapeutics, Yumanity Therapeutics
Leaps by Bayer4Nuvig Therapeutics, ReCode Therapeutics, Nextpoint Therapeutics, Sudo Biosciences
McKesson Ventures3Aetion, BranchLab, Evidation
GV3Science 37, OMass Therapeutics, Rome Therapeutics
dRx Capital2Omada Health, Science 37
M Ventures2Medisafe, Nucleai
Novartis Venture Fund2SpliceBio, Granite Bio
Mass General Brigham Ventures2Abcuro, Lysosomal Therapeutics
Debiopharm Innovation Fund2Nucleai, Voluntis
Alturki Ventures1Omada Health
The Cigna Group Ventures1Omada Health
Intermountain Ventures1Omada Health

Companies backed by the most corporate VCs

Every company on the Sanofi Ventures list

84 companies, as listed on the firm's own website: 60 active, 24 exited.S3 Read the firm's list.

Active 60

  • abcuro
  • AdvanCell Isotopes
  • Aetion
  • Aliada Therapeutics
  • Atalanta Therapeutics
  • Attovia Therapeutics
  • Avilar Therapeutics
  • Bionyra
  • BranchLab
  • Carbon Health
  • Character Biosciences
  • Click Therapeutics
  • Diagonal Therapeutics
  • Draig Therapeutics
  • Eligo Bioscience
  • Empatica
  • Epicrispr Biotechnologies
  • Evidation
  • Expansion Therapeutics
  • Expedition Therapeutics
  • Glycomine
  • Granite Bio
  • i2O Therapeutics
  • Imbria Pharmaceuticals
  • Korsana Biosciences
  • Latigo Bio
  • Lifordi Immunotherapeutics
  • Matchpoint Therapeutics
  • Medisafe
  • Memento Medicines
  • Minervax
  • Mirador Therapeutics
  • Muna Therapeutics
  • Navitor
  • NextPoint Therapeutics
  • Normunity
  • Nucleai
  • Nura Bio
  • Nuvig Therapeutics
  • Odyssey Therapeutics
  • Omada Health
  • OMass Therapeutics
  • Q32 Bio
  • QuantHealth
  • QuantX Biosciences
  • QurAlis
  • ReCode Therapeutics
  • Rezera
  • Rome Therapeutics
  • Science37
  • Splice Bio
  • Star Therapeutics
  • Sudo Biosciences
  • T-Therapeutics
  • Therini Bio
  • Tisento Therapeutics
  • Trial Library
  • Veralox Therapeutics
  • Windward Bio
  • Zag Bio

Exited 24

  • Bluebird Bio
  • Common Sensing
  • Curevo Vaccine
  • Curisium
  • Escient Pharmaceuticals
  • Fate Therapeutics
  • Fulcrum Therapeutics
  • GlycoMimetics
  • Icosavax
  • Immune Design
  • Inozyme Pharma
  • KaloBios
  • Kymera Therapeutics
  • LAVA Therapeutics
  • Lumena Pharmaceuticals
  • Lysosomal Therapeutics
  • MacroGenics
  • Ovid Therapeutics
  • Proteostasis Therapeutics
  • Selecta Biosciences
  • Ultragenyx
  • Unum Therapeutics
  • Voluntis
  • Yumanity Therapeutics

For founders

ItemWhat the firm saysSource
StagesSeed, Series A, Series BS4
Leads roundsYesS4
Pitch pagewww.sanofiventures.com/teamS2

Fund vehicles

VehicleSizeYearSource
Additional multi-year commitment (Sep 2025)USD 625M2025S5

History

  1. Sanofi Ventures inception (Sep 2025 release: since its inception in 2012).S5
  2. Three realized exits with a combined acquisition value of USD 3.25 billion (per Sep 2025 release).S5
  3. Additional USD 625 million multi-year commitment from Sanofi; total assets under management over USD 1.4 billion (24 Sep).S5

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Sanofi Ventures homeFirm
  2. S2Sanofi Ventures teamFirm
  3. S3Sanofi Ventures portfolio (status and location per card)Firm
  4. S4Sanofi Ventures approachFirm
  5. S5Sanofi press release: additional USD 625 million to Sanofi Ventures (24 Sep 2025)Parent company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Sanofi Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.